
Biotechnology • Pharmaceuticals • Science
MindMed is a company that specializes in developing innovative treatments for brain health disorders. It utilizes rigorous scientific methods to create a pipeline of product candidates, particularly focusing on the therapeutic potential of psychedelics and other novel compounds. These treatments aim to address unmet patient needs in areas such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Autism Spectrum Disorder (ASD). MindMed is committed to advancing the research and development of these therapies, although they are not yet approved by the FDA or other health authorities, meaning their safety and efficacy are still under evaluation.
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $30M Post-IPO Equity on 2022-09
November 18
Vice President, Programs and Portfolio Office leading strategic alignment and program management processes at MindMed. Overseeing clinical and research portfolios to improve patient outcomes.
🇺🇸 United States – Remote
💵 $271k - $330k / year
💰 $30M Post-IPO Equity on 2022-09
⏰ Full Time
🔴 Lead
👔 Vice President
November 17
Director, Government Affairs position at Mind Medicine developing government strategies for brain health. Engaging with stakeholders to advance public policy goals and initiatives.
🇺🇸 United States – Remote
💵 $214.6k - $245.4k / year
💰 $30M Post-IPO Equity on 2022-09
⏰ Full Time
🔴 Lead
👔 Director
October 14
Vice President of Market Access leading commercialization strategies for MM120 and pipeline products at MindMed. Overseeing trade, pricing, regulatory compliance, and innovative market access solutions.
🇺🇸 United States – Remote
💵 $293.9k - $350k / year
💰 $30M Post-IPO Equity on 2022-09
⏰ Full Time
🔴 Lead
👔 Vice President